Lixte Biotechnology Ownership | Who Owns Lixte Biotechnology?


OverviewFinancialsChart

Lixte Biotechnology Ownership Summary


Lixte Biotechnology is owned by 1.49% institutional investors, and 98.51% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.43% of its assets in Lixte Biotechnology shares.

LIXT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLixte Biotechnology1.49%-98.51%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20231-90.91%248,084-54.71%11376.60%--100.00%--100.00%
Mar 31, 202311-26.67%547,770-23.02%-162.63%5-16.67%3-
Dec 31, 20221515.38%711,5779.67%-296.02%6-3200.00%
Sep 30, 202213-7.14%648,856-25.66%-134.26%6-14.29%1-75.00%
Jun 30, 20221427.27%872,865-27.88%-69.51%775.00%4-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr49.48K0.43%5.64K
Fidelity Extended Market Index28.62K0.33%869.00
Spartan Extended Market Index Pool F9.45K0.11%-
Fidelity Total Market Index8.52K0.10%-
Fidelity Series Total Market Index7.23K0.08%-
NT Ext Equity Mkt Idx Fd - NL8.98K0.08%-
NT Ext Equity Mkt Idx Fd - DC - NL - T27.04K0.06%-37.00
Spartan Total Market Index Pool G4.26K0.05%-
Spartan Extended Market Index Pool E244.000.01%72.00
Fidelity Nasdaq Composite Index775.000.01%-

Insider Transactions Trends


DateBuySell
2026 Q2--
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--

LIXT Ownership FAQ


Who Owns Lixte Biotechnology?

Lixte Biotechnology shareholders are primarily institutional investors at 1.49%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Lixte Biotechnology's industry, Biotech Stocks , is 382.13%, which Lixte Biotechnology falls below.

Does Blackrock own Lixte Biotechnology?

BlackRock is not among the top 10 institutional shareholders of Lixte Biotechnology.

Who is the top mutual fund holder of Lixte Biotechnology shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Lixte Biotechnology shares, with 0.43% of its total shares outstanding invested in 49.48K Lixte Biotechnology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools